补脑止痫散对癫痫大鼠海马组织GABA_ARα1、NMDAR1、IL-1β及IL-6表达的影响
|
摘要
目的
通过观察戊四氮致痫大鼠在补脑止痫散治疗前后,实验大鼠一般状态、行为学、海马组织病理改变,治疗后大鼠海马组织中GABAARα1、 NMDAR1、IL-1β及I1-6表达的变化,探讨补脑止痫散抗痫机制,为该方临床治疗及预防癫痫疾病提供理论依据。
方法
成年Wistar大鼠55只,在造模前7天随机选取15只大鼠作为补脑止痫散防治组(简称防治组),并进行补脑止痫散灌胃,每日一次。7天后,除防治组外,从40只大鼠中随机选取10只大鼠作为空白组,防治组及其余30只大鼠进行癫痫模型点燃,造模后将30只大鼠中点燃成功的大鼠随机平均分配到模型组、补脑止痫散组。在开始统一灌胃治疗前1天及治疗21天时观察记录4组大鼠的一般状态,称取体质量,记录痫性发作潜伏期和痫性发作级别。通过HE染色及尼氏染色观察海马组织病理学变化情况。免疫组化法检测海马GABAARα1、NMDAR1、IL-1β及I1-6阳性细胞数,计算阳性细胞的平均灰度值。实验数据均输入SPSS17.0进行统计学处理,P<0.05为有显著差异,P<0.01为有高度显著性差异。
结果
共有33只大鼠成功点燃。在灌胃治疗过程中,模型组死亡4只,防治组及补脑止痫散组各死亡1只。
1.一般状态及体质量变化
模型组大鼠一般状态明显较空白组差,防治组、补脑止痫散组与模型组相比均有改善。
灌胃治疗前,与空白组比较,模型组、防治组、补脑止痫散组大鼠体质量均明显减小,有高度显著性差异(P<0.01)；灌胃治疗21天后,与模型组比较,空白组、防治组、补脑止痫散组大鼠的体质量均明显增加,差异具有高度显著性差异(P<0.01)；空白组、模型组、防治组、补脑止痫散组大鼠治疗后的体质量与治疗前各组体质量相比,均有高度显著差异性(P<0.01)。
2.行为学观察
空白组无痫性发作。灌胃治疗前,模型组、防治组、补脑止痫散组间痫性发作潜伏期及发作级别比较无显著差异(P>0.05)。治疗21天后,与模型组比较,防治组、补脑止痫散组大鼠的发作潜伏期均明显延长,具有高度显著性差异(P<0.01)：防治组、补脑止痫散组大鼠治疗后的发作潜伏期与治疗前相比,均有高度显著差异性(P<0.01),2组发作潜伏期均显著延长。治疗21天后,防治组、补脑止痫散组大鼠的发作级别与模型组比较均明显降低,具有高度显著性差异(P<0.01)；防治组、补脑止痫散组大鼠治疗后的发作级别与治疗前相比,均有高度显著差异性(P<0.01),2组发作级别均显著降低。
3.病理学观察
空白组大鼠海马细胞数量和结构均正常。模型组大鼠海马细胞数量明显减少,层次紊乱,细胞肿胀变形,胞浆染色加深,胞核固缩、碎裂。防治组、补脑止痫散组较模型组均有改善。
4.GABAARα1的表达情况
与空白组比较,模型组大鼠海马的GABAARα1阳性细胞数目明显减少,平均灰度值明显增高,且均有高度显著性差异(P<0.01)；与模型组比较,防治组、补脑止痫散组癫痫大鼠海马的GABAARα1阳性细胞数均明显增加,平均灰度值均明显降低,防治组与模型组比较GABAARα1阳性细胞数及平均灰度值均有高度显著性差异(P<0.01),补脑止痫散组与模型组比较GABAARα1阳性细胞数及平均灰度值均有显著性差异(P<0.05)。
5.NMDAR1的表达情况
与空白组比较,模型组大鼠海马的NMDAR1阳性细胞数明显增高,平均灰度值明显降低,均有高度显著性差异(P<0.01)；与模型组比较,防治组、补脑止痫散组癫痫大鼠海马的NMDAR1阳性细胞数均明显降低,平均灰度值均明显增高,防治组与模型组比较NMDAR1阳性细胞数及平均灰度值均有高度显著性差异(P<0.01),补脑止痫散组与模型组比较NMDAR1阳性细胞数及平均灰度值均有显著性差异(P<0.05)。
6.IL-1p的表达情况
与空白组比较,模型组大鼠海马的IL-1p阳性细胞数明显增高,平均灰度值明显降低,且均有高度显著性差异(P<0.01)。与模型组比较,防治组、补脑止痫散组癫痫大鼠海马的IL-1β阳性细胞数均明显降低,平均灰度值均明显增高,防治组与模型组比较IL-1p阳性细胞数及平均灰度值均有高度显著性差异(P<0.01),补脑止痫散组与模型组比较IL-1p阳性细胞数及平均灰度值均有显著性差异(P<0.05)。
7.IL-6的表达情况
与空白组比较,模型组大鼠海马的IL-6阳性细胞数明显增高,平均灰度值明显降低,且均有高度显著性差异(P<0.01)。与模型组比较,防治组、补脑止痫散组癫痫大鼠海马的IL-6阳性细胞数均明显降低,平均灰度值均明显增高,防治组与模型组比较IL-6阳性细胞数及平均灰度值均有高度显著性差异(P<0.01),补脑止痫散组与模型组比较IL-6阳性细胞数及平均灰度值均有显著性差异(P<0.05)。
结论
1.中药补脑止痫散可明显改善戊四氮致痫大鼠的一般状态,纠正其体质量减轻。
2.补脑止痫散能明显延长癫痫大鼠发作潜伏期,降低痫性发作级别。
3.中药补脑止痫散可明显减轻海马神经元的病理损伤。
4.中药补脑止痫散能增强GABAARα1的表达,防治组作用强于补脑止痫散组。
5.中药补脑止痫散抑制NMDARl的表达,防治组作用强于补脑止痫散组。
6.中药补脑止痫散抑制IL-1β的表达,防治组作用强于补脑止痫散组。
7.中药补脑止痫散抑制IL-6的表达,防治组作用强于补脑止痫散组。
Objective:
Observe the general state, behavior changes, hippocampal tissue pathological changes of PTZ induced epilepsy rats before and after treatment.Observe GABAARα1, NMDAR1, IL-1β and IL-6of hippocampal tissue of PTZ induced epilepsy rats after treatment. Discuss the mechanism of the resistance to epilepsy of Bunaozhixian power.Provide the theory basis to prevent and treat epilepsy with Bunaozhixian power.
Methods:
7days before rats model establish, take15rats as Bunaozhixian power prevention group(be called prevention group for short) randomly from55adult Wistar rats.Give a gavage of Bunaozhixian power to prevention group rats once a day.After7days,start to establish epilepsy model rats with the other30rats and prevention rats.Divide randomly model rats into model group and Bunaozhixian power group.Observe the general state,weight, seizure latency and seizure level of before and after treatment.Observe hippocampal tissue pathological changes of PTZ induced epilepsy rats after treatment in HE staining and Nissl's staining.Detect number of positive cells and its'average gray value of GABAARal,NMDARl,IL-1β,Il-6by immunohistochemical.Input the data into SPSS17.0,P<0.05means significant difference.P<0.01means highly significant difference.
Results:
There are33rats were established successfully.During the gavage, there were4rats dead in model group,1rat dead in prevention group and1rat dead in Bunaozhixian power group.
1. The change of general state and weight
Model group rats' general state is worse than blank group rats. Compare with model group,prevention group and Bunaozhixian power group rats have improvement.
Compare with blank group, before gavage,all the experiment rats' weight decrease obviously,has highly significant difference(P<0.01).Compare with model group, after gavage therapy,all other group rats'weight increase obviously,has highly significant difference(P<0.01).All rats' after treatment weight are obviously different from before treatment weight,has highly significant difference(P<0.01).
2. The behavioral observation
Blank group has no epileptic seizure.There is no difference between model group,Bunaozhixian power group and prevention group before treatment(P>0.05).Compare with model group,prevention group and Bunaozhixian power group rats'seizure latency and seizure level are obviously prolong,has highly significant difference(P<0.01).Prevention group and Bunaozhixian power group rats'before treatment seizure latency and seizure level are highly significant difference(P<0.01) from after treatment seizure latency and seizure level.The seizure latency all obviously prolong.The seizure level all obviously decrease.
3. The pathological observation
Blank group rats hippocampal cells number and structure are all normal.Number of model group rats hippocampal cells decreased significantly structure disordered, cell swelling deformation, cytoplasm staining, cell nucleus pycnosis, fracture.Prevention group and Bunaozhixian power group were improved.
4. The expression of GABAAR alpha1
Blank group GABAAR alpha1positive cells number is more,AGV is lower.Compare with blank group,number of model group decreased significantly, AGV increased significantly,highly significant difference (P<0.01);Compared with model group, prevention group, Bunaozhixian power group epilepsy rat hippocampal GABAAR alpha1expression were significantly increased, prevention group has highly significant difference (P <0.01);Bunaozhixian power group has significant difference (P<0.05).5.The expression of NMDAR1
Compared with the blank group, model group rats hippocampal NMDAR1expression increased obviously, there are highly significant difference (P<0.01);Compared with model group, prevention group, Bunaozhixian power group were significantly reduced in the rat hippocampus of NMDAR1expression, prevention and treatment group compared with model group was highly significant difference (P<0.01), Bunaozhixian power group compared with model group had significant difference (P<0.05).
6. The expression of IL-1beta
Compared with the blank group, model group rats hippocampal NMDAR1expression increased obviously, there are highly significant difference (P<0.01);Compared with model group, prevention group, Bunaozhixian power group were significantly reduced in the rat hippocampus of NMDAR1expression, prevention and Bunaozhixian power group compared with model group was highly significant difference (P<0.01), Bunaozhixian power group compared with model group had significant difference (P<0.05).
7.The expression of IL-6
Compared with the blank group, model group rats hippocampal significantly higher, IL-6expression was highly significant difference (P<0.01).Compared with model group, prevention group, Bunaozhixian power group rat hippocampus of IL-6expression were significantly lower, prevention and treatment group compared with model group was highly significant difference (P<0.01), Bunaozhixian power group compared with model group had significant difference (P<0.05).
Conclusion:
1. Bunaozhixian power can obviously improve the PTZ epilepsy rats'general status, correct its body quality loss.
2. Bunaozhixian power can prolong seizure latency and decrease seizure level.
3. Bunaozhixian power can reduce the pathological damage of hippocampal neurons.
4.Bunaozhixian power can strengthen the expression of GABAARα1.Prevention group is more effective than Bunaozhixian power group.
5. Bunaozhixian power can restrain the expression of NMDAR1.Prevention group is more effective than Bunaozhixian power group.
6. Bunaozhixian power can restrain the expression of IL-1β.Prevention group is more effective than Bunaozhixian power group.
7. Bunaozhixian power can restrain the expression of IL-6.Prevention group is more effective than Bunaozhixian power group.
通过观察戊四氮致痫大鼠在补脑止痫散治疗前后,实验大鼠一般状态、行为学、海马组织病理改变,治疗后大鼠海马组织中GABAARα1、 NMDAR1、IL-1β及I1-6表达的变化,探讨补脑止痫散抗痫机制,为该方临床治疗及预防癫痫疾病提供理论依据。
方法
成年Wistar大鼠55只,在造模前7天随机选取15只大鼠作为补脑止痫散防治组(简称防治组),并进行补脑止痫散灌胃,每日一次。7天后,除防治组外,从40只大鼠中随机选取10只大鼠作为空白组,防治组及其余30只大鼠进行癫痫模型点燃,造模后将30只大鼠中点燃成功的大鼠随机平均分配到模型组、补脑止痫散组。在开始统一灌胃治疗前1天及治疗21天时观察记录4组大鼠的一般状态,称取体质量,记录痫性发作潜伏期和痫性发作级别。通过HE染色及尼氏染色观察海马组织病理学变化情况。免疫组化法检测海马GABAARα1、NMDAR1、IL-1β及I1-6阳性细胞数,计算阳性细胞的平均灰度值。实验数据均输入SPSS17.0进行统计学处理,P<0.05为有显著差异,P<0.01为有高度显著性差异。
结果
共有33只大鼠成功点燃。在灌胃治疗过程中,模型组死亡4只,防治组及补脑止痫散组各死亡1只。
1.一般状态及体质量变化
模型组大鼠一般状态明显较空白组差,防治组、补脑止痫散组与模型组相比均有改善。
灌胃治疗前,与空白组比较,模型组、防治组、补脑止痫散组大鼠体质量均明显减小,有高度显著性差异(P<0.01)；灌胃治疗21天后,与模型组比较,空白组、防治组、补脑止痫散组大鼠的体质量均明显增加,差异具有高度显著性差异(P<0.01)；空白组、模型组、防治组、补脑止痫散组大鼠治疗后的体质量与治疗前各组体质量相比,均有高度显著差异性(P<0.01)。
2.行为学观察
空白组无痫性发作。灌胃治疗前,模型组、防治组、补脑止痫散组间痫性发作潜伏期及发作级别比较无显著差异(P>0.05)。治疗21天后,与模型组比较,防治组、补脑止痫散组大鼠的发作潜伏期均明显延长,具有高度显著性差异(P<0.01)：防治组、补脑止痫散组大鼠治疗后的发作潜伏期与治疗前相比,均有高度显著差异性(P<0.01),2组发作潜伏期均显著延长。治疗21天后,防治组、补脑止痫散组大鼠的发作级别与模型组比较均明显降低,具有高度显著性差异(P<0.01)；防治组、补脑止痫散组大鼠治疗后的发作级别与治疗前相比,均有高度显著差异性(P<0.01),2组发作级别均显著降低。
3.病理学观察
空白组大鼠海马细胞数量和结构均正常。模型组大鼠海马细胞数量明显减少,层次紊乱,细胞肿胀变形,胞浆染色加深,胞核固缩、碎裂。防治组、补脑止痫散组较模型组均有改善。
4.GABAARα1的表达情况
与空白组比较,模型组大鼠海马的GABAARα1阳性细胞数目明显减少,平均灰度值明显增高,且均有高度显著性差异(P<0.01)；与模型组比较,防治组、补脑止痫散组癫痫大鼠海马的GABAARα1阳性细胞数均明显增加,平均灰度值均明显降低,防治组与模型组比较GABAARα1阳性细胞数及平均灰度值均有高度显著性差异(P<0.01),补脑止痫散组与模型组比较GABAARα1阳性细胞数及平均灰度值均有显著性差异(P<0.05)。
5.NMDAR1的表达情况
与空白组比较,模型组大鼠海马的NMDAR1阳性细胞数明显增高,平均灰度值明显降低,均有高度显著性差异(P<0.01)；与模型组比较,防治组、补脑止痫散组癫痫大鼠海马的NMDAR1阳性细胞数均明显降低,平均灰度值均明显增高,防治组与模型组比较NMDAR1阳性细胞数及平均灰度值均有高度显著性差异(P<0.01),补脑止痫散组与模型组比较NMDAR1阳性细胞数及平均灰度值均有显著性差异(P<0.05)。
6.IL-1p的表达情况
与空白组比较,模型组大鼠海马的IL-1p阳性细胞数明显增高,平均灰度值明显降低,且均有高度显著性差异(P<0.01)。与模型组比较,防治组、补脑止痫散组癫痫大鼠海马的IL-1β阳性细胞数均明显降低,平均灰度值均明显增高,防治组与模型组比较IL-1p阳性细胞数及平均灰度值均有高度显著性差异(P<0.01),补脑止痫散组与模型组比较IL-1p阳性细胞数及平均灰度值均有显著性差异(P<0.05)。
7.IL-6的表达情况
与空白组比较,模型组大鼠海马的IL-6阳性细胞数明显增高,平均灰度值明显降低,且均有高度显著性差异(P<0.01)。与模型组比较,防治组、补脑止痫散组癫痫大鼠海马的IL-6阳性细胞数均明显降低,平均灰度值均明显增高,防治组与模型组比较IL-6阳性细胞数及平均灰度值均有高度显著性差异(P<0.01),补脑止痫散组与模型组比较IL-6阳性细胞数及平均灰度值均有显著性差异(P<0.05)。
结论
1.中药补脑止痫散可明显改善戊四氮致痫大鼠的一般状态,纠正其体质量减轻。
2.补脑止痫散能明显延长癫痫大鼠发作潜伏期,降低痫性发作级别。
3.中药补脑止痫散可明显减轻海马神经元的病理损伤。
4.中药补脑止痫散能增强GABAARα1的表达,防治组作用强于补脑止痫散组。
5.中药补脑止痫散抑制NMDARl的表达,防治组作用强于补脑止痫散组。
6.中药补脑止痫散抑制IL-1β的表达,防治组作用强于补脑止痫散组。
7.中药补脑止痫散抑制IL-6的表达,防治组作用强于补脑止痫散组。
Objective:
Observe the general state, behavior changes, hippocampal tissue pathological changes of PTZ induced epilepsy rats before and after treatment.Observe GABAARα1, NMDAR1, IL-1β and IL-6of hippocampal tissue of PTZ induced epilepsy rats after treatment. Discuss the mechanism of the resistance to epilepsy of Bunaozhixian power.Provide the theory basis to prevent and treat epilepsy with Bunaozhixian power.
Methods:
7days before rats model establish, take15rats as Bunaozhixian power prevention group(be called prevention group for short) randomly from55adult Wistar rats.Give a gavage of Bunaozhixian power to prevention group rats once a day.After7days,start to establish epilepsy model rats with the other30rats and prevention rats.Divide randomly model rats into model group and Bunaozhixian power group.Observe the general state,weight, seizure latency and seizure level of before and after treatment.Observe hippocampal tissue pathological changes of PTZ induced epilepsy rats after treatment in HE staining and Nissl's staining.Detect number of positive cells and its'average gray value of GABAARal,NMDARl,IL-1β,Il-6by immunohistochemical.Input the data into SPSS17.0,P<0.05means significant difference.P<0.01means highly significant difference.
Results:
There are33rats were established successfully.During the gavage, there were4rats dead in model group,1rat dead in prevention group and1rat dead in Bunaozhixian power group.
1. The change of general state and weight
Model group rats' general state is worse than blank group rats. Compare with model group,prevention group and Bunaozhixian power group rats have improvement.
Compare with blank group, before gavage,all the experiment rats' weight decrease obviously,has highly significant difference(P<0.01).Compare with model group, after gavage therapy,all other group rats'weight increase obviously,has highly significant difference(P<0.01).All rats' after treatment weight are obviously different from before treatment weight,has highly significant difference(P<0.01).
2. The behavioral observation
Blank group has no epileptic seizure.There is no difference between model group,Bunaozhixian power group and prevention group before treatment(P>0.05).Compare with model group,prevention group and Bunaozhixian power group rats'seizure latency and seizure level are obviously prolong,has highly significant difference(P<0.01).Prevention group and Bunaozhixian power group rats'before treatment seizure latency and seizure level are highly significant difference(P<0.01) from after treatment seizure latency and seizure level.The seizure latency all obviously prolong.The seizure level all obviously decrease.
3. The pathological observation
Blank group rats hippocampal cells number and structure are all normal.Number of model group rats hippocampal cells decreased significantly structure disordered, cell swelling deformation, cytoplasm staining, cell nucleus pycnosis, fracture.Prevention group and Bunaozhixian power group were improved.
4. The expression of GABAAR alpha1
Blank group GABAAR alpha1positive cells number is more,AGV is lower.Compare with blank group,number of model group decreased significantly, AGV increased significantly,highly significant difference (P<0.01);Compared with model group, prevention group, Bunaozhixian power group epilepsy rat hippocampal GABAAR alpha1expression were significantly increased, prevention group has highly significant difference (P <0.01);Bunaozhixian power group has significant difference (P<0.05).5.The expression of NMDAR1
Compared with the blank group, model group rats hippocampal NMDAR1expression increased obviously, there are highly significant difference (P<0.01);Compared with model group, prevention group, Bunaozhixian power group were significantly reduced in the rat hippocampus of NMDAR1expression, prevention and treatment group compared with model group was highly significant difference (P<0.01), Bunaozhixian power group compared with model group had significant difference (P<0.05).
6. The expression of IL-1beta
Compared with the blank group, model group rats hippocampal NMDAR1expression increased obviously, there are highly significant difference (P<0.01);Compared with model group, prevention group, Bunaozhixian power group were significantly reduced in the rat hippocampus of NMDAR1expression, prevention and Bunaozhixian power group compared with model group was highly significant difference (P<0.01), Bunaozhixian power group compared with model group had significant difference (P<0.05).
7.The expression of IL-6
Compared with the blank group, model group rats hippocampal significantly higher, IL-6expression was highly significant difference (P<0.01).Compared with model group, prevention group, Bunaozhixian power group rat hippocampus of IL-6expression were significantly lower, prevention and treatment group compared with model group was highly significant difference (P<0.01), Bunaozhixian power group compared with model group had significant difference (P<0.05).
Conclusion:
1. Bunaozhixian power can obviously improve the PTZ epilepsy rats'general status, correct its body quality loss.
2. Bunaozhixian power can prolong seizure latency and decrease seizure level.
3. Bunaozhixian power can reduce the pathological damage of hippocampal neurons.
4.Bunaozhixian power can strengthen the expression of GABAARα1.Prevention group is more effective than Bunaozhixian power group.
5. Bunaozhixian power can restrain the expression of NMDAR1.Prevention group is more effective than Bunaozhixian power group.
6. Bunaozhixian power can restrain the expression of IL-1β.Prevention group is more effective than Bunaozhixian power group.
7. Bunaozhixian power can restrain the expression of IL-6.Prevention group is more effective than Bunaozhixian power group.
引文
[1]Enjel J, Jr. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy:Report of the ILAE Task Force on Classification and Terminology[J]. Epilepsia 2001;42:796-803.
[2]Sadi-Pooya A.A, Hojabri K.Risk factors for childhood epilepsy:a case-control study. Epilepsy & Behavior,2005,6(2):203-206.
[3]Daoud A.S, Batieha A, Bashtawi M,et al.Risk factors for childhood epilepsy:a case-control study from Irbid,Jordan[J].Seizure,2003,12(3):170-174.
[4]曾军,洪震,黄茂盛等.人群癫痫危险因素及社会心理因素病例对照研究.中华流行病杂志,2003,24(2)：116-118.
[5]Liang J, Zhang Y, Chen Y, et al.Common polymorphisms in the CACNAIH gene associated with childhood absence epilepsy in Chinese Han population.[J]Ann Hum Genet.2007,71(Pt 3):325-35
[6]Cruneli V, Leresche N. Childhood absence epilepsy:genes, channels, neurons and networks[J].Nat Rev Neurosci.2002;3:371-82
[7]Gourfinkel-An I, Baulac S, Nabbout R, Ruberg M, Baulac M, Brice A et al.Monogenic idiopathic epilepsies[J]. Lancet Neurol.2004;3:209-18
[8]Delgado-Escueta AV, Medina MT, Serratosa JM, Castroviejo IP, Gee MN, Weissbecker K et al.Mapping and positional cloning of common idiopathic generalized epilepsies:juveile myoclonus epilepsy and childhood absence epilepsy[J].Adv Neurol 1999;79:351-74
[9]Jones-Davis DM,Macdonald RL.GABA(A) receptor function and pharmacology in epilepsy and status epilepticus[J]. Curr Opin Pharmacol.2003;3:12-8
[10]Lerche H,Jurkat-Rott K, Lehmann-Horn F. Ion channel and epilepsy[J]. Am J Med Genet,2001,106(2):146-159.
[11]Wallace RH,Wang DW,Singh R,et al.Febrile seizures and generalized epilepsy associated with a mutation in the Na+channelβ1 subunit gene SCNlB[J].Nat Gent, 1998,19(4):366-370.
[12]Steinlein OK,Noebels JL.Ion channel and epilepsy in man and mouse[J].Curr Opin Genet Dev,2000,10(3):286-291.
[13]Cossette P,、liu L,Brisebois K,et al. Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy.Nat Genet[J],2002,31 (2):184-189
[14]Haug K, Warnstedt M, Alekov AK,et al.Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies[J].Nat Genet,2003,33(4):527-532[15]胡元元,何善述,徐仁泗,等.神经元GABA合成、分解和分泌与癫痫发病的研究[J].中风与神经疾病杂志,2002,18(3)：134-136.
[16]郭文GABAA受体的研究进展[J].国外医学生理、病理科学与临床分册,1999,19(3)：161-164.
[17]Freund TF, Katona I. Perisomatic inhibition[J]. Neuron,2007,56:33-42.
[18]张力,张丹参,张士善.外周GABA受体研究进展[J].中国药理学通报,1990.
[19]王尧,杜子威.神经生物化学与分子生物学[M].北京：人民卫生出版社,1997.
[20]Houser CR,Eselapez M.Vulnerability and plastieity of the GABA system in the pilocarpine model of spontaneous recurrent seizures[J]. Epilepsy Res,1996,26(I):207-218
[21]Bormann J.Trends Pharmacol Sci[J].2000,21:16-19
[22]小川纪雄,冯剑波译.脑受体[M].北京：北京医科大学中国协和医科大学联合出版社,1997.
[23]Misgeld U,Bijak M,Jarolimek W.A physiological role for GABAB receptors and the effects of baclofen in the mammalian central nervous system[J].Prog Neurobiol,1995,46(4):423-462
[24]Simon J,Wakimoto H,Fujita N,et al.Analysis of the set of GABAA receptor genes in the human genome[J]. Biol Chem,2004,279(40):41422-41435
[25]Corringer PJ, Le Novere N,Changeux JP.Nicotinic receptors at the amino acid level[J].Annu Rev Pharmacol Toxicol,2000,40:431-458
[26]McKernan RM,Whiting pJ.Which GABAA-receptor subtypes really occur in the brain?Trends Neurosci,1996,19(4):139-14
[27]Lynch M, Sutula T. Recurrent excitatory connectivity in the dentate gyrus of kindled and kainic acid-treated rats[J].J Neurophysiol,2000,83(2):693-704.
[28]Fukao K,Momiyama T,Ishihara K,et al.Inhibition by γ-aminobutyric acid system activation of epileptic seizures in spontaneously epileptic rats[J].Jpn J Pharmacol,1998,76(4):387-396
[29]Rossler AS,Launay JM,Venaut P,et al.Change in benzodiazepine binding in a subkindling situation[J]. Epilepsia,2000,41(Suppl 6):586.
[30]Gibbs JWIII,Shumate MD,Coulter DA.Differential epilepsy associated alterations in postsynaptic GABAA receptor function in dentate granule and CA1 neurons[J].J Neurophysiol,1997,77(4):1924-193
[31]Gibbs JWIII,Berkow SG,Morton L,et al.Physiological analysis of Rasmussen's encephalitis:Patch clamp recordings of altered inhibitory neurotransmitter function in ressected frontal cortical tissue.Epilepsia,1996,37(suppl 5):79
[32]薄涛,陈勇,毛定安,等.新生大鼠反复惊厥对脑内Y-氨基丁酸A受体α1和γ2亚单位表达的长期影响[J].北京大学学报(医学版),2006,38(6)：628-633.
[33]陆钦池,苗玲,蔡琰.癫痫持续大鼠模型的GABAA受体亚单位αl的mRNA表达及受体配体结合的变化[J].脑与神经疾病杂志,2001,9(3)：133-136
[34]Loup F,Wieser HG,Yonekawa Y,et al.Selective alterations in GABAA receptor subtypes in human temporal lobe epilepsy[J].J Neurosci,2000,20(14):5401-5419.
[35]]Meguro R,Lu ZW,Gavrilovici C,et al.Static.transient and permanent organisation of GABAA[J].Neurochemistry,2004,91(1):144
[36]刘智良,徐如祥,姚志彬,等GABAB受体对大鼠海马CA1区锥体细胞突触传递的作用[J].中华神经医学杂志,2006.
[37]Grifa A,Totaro A,Rommen S JM,et al.GABA(gamma-aminobutyric acid)neurotransmission:identification and fine mapping of human GABAB receptor gene[J].Biochem Biophys Res Commun,1998,50(2):240-245.
[38]KauPmann K,huggel K,Heid J,et al.Expression cloning of GABAB-receptors uncovers similarity to metabotropic glutamate receptors[J].Nature,1997,386(6622):239-246.
[39]Furtinger S,Bettle B,Sperk G.Altered expression of GABAB receptor in the hippocampus after kainic acid-induced seizure n rats[J].Mol Brain Res,2003,113(1):107-115.
[40]陆钦池,蔡琐.AY-9944大鼠失神样痫性发作模型的GABAB受体R1亚单位基因表 达改变[J].脑与神经疾病杂志,2002,10(5)：279-281
[41]Sehuler V,Lusehe C,Blanehet C,et al.Epilepsy,hyperalgesia,impaired memory,and loss of pre-and postsynaptic GABA(B) responses in mice lacking GABA(B(1))[J]. Neuron,2001,31(1):47-58
[42]Gambardella A,Manna I,Labate A,et al.GABA(B) receptorl polymorphism(G1465A) s associated with temporal obe epilepsy)[J].Neurology,2003,60(4):560-563
[43]Avoli M,Benini R,Guzman P,et al.GABA(B) receptor activation and limbic network ictogenesis)[J].Neuropharmacology,2004,46(1):43-51
[44]Bowery NG, Enna S J.y-Amino butyric acid B receptors:first of the functional metabotropic heterodimers. Pharmacol[J].Exp,2000,292:1-7.
[45]Chebib M,Johnston GA.The"ABC"ofGABA receptors:a brief review[J].Clin Exp Pharmacol Physiol,1999,26(11):937-940
[46]Graham AR,Johnston,Phan KL,et al.GABAc receptors as drug targets[J].Curr Drug Targ CNS Neurol Disord,2003,2(4):260-269
[47]Lloyd KG,Bossi L,Morselli PL,et al.Alterations of GABA-mediated synaptic transmission in human epilepsy[J].Adv Neurol.1986;44:1033-44.
[48]Savic I.Persson A,Roland P,et al.In-vivo demonstration of reduced Benzodiazepine receptor binding n human epileptic foe i[J].Lancet.1988; 15;2(8616):863-6
[49]王晓梅,关毅敏,张文利,等.癫痫患者脑脊液中GABA、Glu、As的变化及其临床意义[J].中风与神经疾病杂志,1996,13(6)：348-350.
[50]田发发.点燃癫痫模型中脑组织兴奋性氨基酸的变化[J].湖南医科大学学报,2002,27(4)：319-31].
[51]Dingledine R,Borges K,Bowie D,et al.The glutamate receptor ion channels[J]. Pharmacological Reviews,1999,51(1):7-61
[52]Paoletti P,Neyton J.NMDA receptor subunits:function and pharmacology[J].Current Opinion in Pharmacology,2007,7(1):39-47
[53]Chrysanthy J,Friederike B,Miehael M,et al.Bloekade of NMDA receptors and apoptic neurodegeneration in the developing brain[J].Seienee,1999,283:7
[54]Yu SP,Yeh CH,Strasser U,et al.NMDA receptor mediated K+effiux and neuronal apoptosis[J].Science,1999,284:336
[55]Angeka CE, Robert KS, Shih-Chieh C, et al. Role of synaptic metabotropic glutamate receptors in epileptic form discharges in hippocampal slices[J].J Neurophysiol,2002,88(4):1625-1633.
[56]Bo T, Jiang Y, Cao H, et al. Long-term effects of seizures in neonatal rats on spatial learning ability and N-methyl-D-aspartate receptor expression in the brain[J].Brain Res Dev Brain Res,2004,152(2):137-142.
[57]Wang F, Smith NA,Xu Q,Fujita T,Baba A,Matsuda T,Takano T, Bekar L, Nedergaard M.Astrocytes modulate neural network activity by Ca2+-dependent uptake of extracellular K+[J].Sci Signal 2012;5(218):26
[58]Nedergaard M, Verkhratsky A.Artifact versus reality-How astrocytes contribute to synaptic events[J].Glia.2012. doi:10.1002/glia.22288.
[59]Appaix F.Girod S,Boisseau S,Romer J,Vial JC,Albrieux M,Maurin M,Depaulis A, Guillemain I, van der Sanden B.Specific in vivo staining of astrocytes in the whole brain after intravenous injection of sulforhodamine dyes[J].PLoS One 2012;7(4):e35169
[60]Oberheim NA,Tian GF,Han XN,et al.Loss of Astrocytic Domain Organization in the Epileptic Brain[J].J Neurosci 2008;28(13) 3264-3276
[61]Simatov R,Crispino M,Hoe W,et al.Changes in expression of neuronal and glial glutamate transportersin rat hippocampus following kainite induced seisure activity[J].Brain Res,1999,65 (1):112-116.
[62]Turrin NP,Rivest S.Innate immune reaction in response to seizures:implications for the neuropathology associated with epilepsy[J]. Neurobiology,2004,16(2) 321-334.
[63]杜静,方敏,龚非力,等.癫痫患者脑组织TNF-αmRNA、IL-6 mRNA以及HLA-Ⅱ抗原表达的改变[J].同济医科大学学报,2000,29(2)：111-113.
[64]Minami M, Kuraishi Y,Yamaguchi T,et al.Convulsants induce interleukin-1 beta messenger RNA in rat brain [J]. Biochem Biophys Res Commun,1990,171 (2):832-837.
[65]Vezzani A,Conti M,De Luigi A,et al.Interleukin-lbeta immunoreactivity and micro glia are enhanced in the rat hippocampus by focal kainate application:functional evidence for enhancement of electrographic seizures[J].J Neurosci,1999,19(12):256-5065.
[66]李平,李正莉,朱长庚,等.白细胞介素-1p对Fos蛋白表达的影响及其在癫痫发作中的作用[J].中国组织化学与细胞化学杂志,2003,12(3)：245-249
[67]牛廷献,罗晓红,史智勇,高福兴.癫痫大鼠血清和脑组织IL-1β、IL-6和TNF-α水平变化[J].放射免疫学杂志,2005,18(4)：256-259
[68]Hirano T, Yasukawa k, Harada H,et al. Complementary DNA for a novel human interleukin (BSF-2) that nduced B-lymphocytes to produce immunoblobulins[J].Nature,1986,324:73-76.
[69]Muraguchi AT,Hirano B,Tang T,et al.The essential role of B cell stimulatory factor 2(BSF-2/IL-6) for the terminal differentiation of B-cells[J].J Exp Med,1988, 167:332-344.
[70]Guerne PA,Carson DA,Lotz M. IL-6 production bu human articular chondrocytes [J]. J Immunol,1990,144:499-505.
[71]Campell IL,Abraham CR,Masliah E,et al.Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin-6[J].Pro Natl Acad Sci USA.1993,90(21):10061.
[72]Petloal J.Palmio J,Korhonen L,el al.Interleukin-6 and interleukin-1 erceptor antagonist in cerebrospinal fluid from patients with recent tonic-clonic seizures[J].Epilepsy Res,2000,41(3):205-211.
[73]杜静,方敏,龚非力,等.癫痫患者脑组织TNF-αmRNA、IL-6 mRNA以及HLA-Ⅱ抗原表达的改变[J].同济医科大学学报,2000,29(2)：111-113.
[74]ZHU Xiaoxin,LI Zhengli,ZHU Changgen,et al.Changes in Behavior and Amino Acid Neurotransmitters in the Brain of Rats with Seizure Induced by IL-1 or IL-6[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2005,25(3):236-239.
[75]Crespel A,Coubes P,,Rousset MC,Brana C, Rougier A, Rondouin G, Bockaert J, Baldy-Moulinier M, Lerner-Natoli M.2002. Inflammatory reactions in human medial temporal lobe epilepsy with hippocampal sclerosis[J]. Brain Res 952:159-169.
[76]Kharatishvili I, Nissinen JP, McIntosh TK, Pitkanen A.2006. A model of posttraumatic epilepsy induced by lateral fluid-percussion brain injuryin rats[J]. Neuroscience 140:685-697.
[77]Pitkanen A, Immonen RJ, Grohn OH, Kharatishvili I.2009. From traumatic brain injury to posttraumatic epilepsy:what animal models tell us about the process and treatment options[J]. Epilepsia 50(Suppl 2):21-29.
[78]Hayashi K, Ueshima S, Ouchida M, Mashimo T, Nishiki T, Sendo T, Serikawa T, Matsui H, Ohmori I.2011. Therapy for hyperthermia-induced seizures in Scnla mutant rats[J]. Epilepsia 52:1010-1017.
[79]Zheng XY, Zhang HL, Luo Q, Zhu J.2011. Kainic acid-induced neuro-degenerative model:potentials and limitations[J]. J Biomed Biotechnol 2011:457079.
[80]Bae EK, Jung KH, Chu K, Lee ST, Kim JH, Park KI, Kim M, Chung CK, Lee SK, Roh JK.2010. Neuropathologic and clinical features of human medial temporal lobe epilepsy[J]. J Clin Neuro16:73-80.
[81]Yang T, Zhou D, Stefan H.2010. Why mesial temporal lobe epilepsy with hippocampal sclerosis is progressive:uncontrolled inflammation drives disease progression[J]. J Neurol Sci 296:1-6.
[82]C P Panayiotopoulos,吴立文,任连坤,等.癫痫-发作和综合征的诊断与治疗[M].北京：中国协和医科大学出版社,2008：455-485
[83]Webster WS, Howe AM, Abela D,et al.The relationship between cleft lip,maxillary hypoplasia,hypoxia and phenytoin[J].Curr Pharm Des,2006,12(12):1431-1448.
[84]Yasser Y.Obstetric and gynecologic care of women with epilepsy[J]. Epilepsia,1998,39(Suppl18):S17
[85]Samren EB,Cornelia MVD,Chritiaens GCML.et al.Antiepileptic drug regimens and major congenital abnormalities in the offspring[J].Ann Neurol,1997,46(5):739
[86]Cerminara C,Montanaro ML,Curatolo P,et al.Lamotrigine induced seizure aggravation and negative myoclonus n diopathic rolandic epilepsy[J].Neurology,2004,63(2):373-375.
[87]Sazgar M,Bourgeo is BF.Aggravation of epilepsy by antiepileptic drugs[J]. Pediatr Neurol,2005,33(4):227-234.
[88]冯波,王建军,魏装鹏,等.外伤性癫痫136例临床分析[J].临床外科杂志,2008,16(6)419-420.
[89]晋金兰,庄汉屏,陈英.脑外伤后癫痫的临床研究进展[J].中国临床神经学,2007,15(1)：87-91.
[90]公方和,漆松涛,刘承勇,邱炳辉.抗癫痫药对神经外科手术后癫痫的预防作用[J].广东医学,2006,27(2)：268-269.
[91]LFM Beenen,J Lindeboom,DGA Kasteleijn-Nolst Trenite,et al.Comparative Domparative double blind clinical trial of phenytoin and sodium valproate as anticonvulsant prophylaxis after craniotomy:efficacy,tolerability,and cognitive effects[J].Neurol Neurosurg Psychiatry,1999.67:474-480.
[92]Angeleri F,Majkowski J,Cacchio G,et al.Post traumatic epilepsy risk factors:one year pospective study after head injury[J].Epilepsia40.1222-1230.
[93]Temkin NR,Dikmen SS,Anderson GD,et al.Valproate therapy for prevention of posttraumatic seizures:a randomized trial[J].J Neurisurg1999.91:593-600.
[94]许文洲.从经方治痫验案谈其临床分型[J].中国民间疗法,2001,9(6)：8-9.
[95]王建国,邵景云.石葛蒲治癫痫大发作有良效[J].四川中医,1996,14(11)：23
[96]杨安婷,林秀萍.中药赭石治疗小儿癫痫121例临床体会[J].黑龙江中医药,1998,(5)：269
[97]高广英,范珍花.蜥蜴治疗小儿癫痫2例[J].中国民族民间医药杂志,2001,(51)：245
[98]王晓鹏,耿连霞,焦玉平,等.刺五加的抗癫痫作用及分析[J].河北中医,1998,20(5)：269-270,
[99]解旭东,冀风云,王婷,等.银杏叶提取物辅助治疗癫痫临床观察[J].脑与神经疾病杂志,2000,8(3)：172-173.
[100]邓元江,王净净.穴位埋线加小剂量抗痫西药治疗癫痫全身强直阵挛发作临床观察[J].中国针灸,2001,21(5)：271
[101]尚希贤.中医防治癫痫初探[J].陕西中医,1996,17(5)：212-213.
[102]榻达科,张汉伟,张刚利,赵利军.穴位埋线对癫痫大鼠急性发作潜伏期及体重的影响[J].实验中医药学.2012,13(2)：26-29.
[103]杜淑娟,杨丽新.袁美凤教授治疗癫痫经验[J].山西中医学院学报,2006,7(3)： 45-46.
[104]符冰,李红,张家维.辨证取穴药线埋植治疗癫痫的临床研究[J].甘肃中医,2004,17(9)：1
[105]杨丽卿,岳旺,王蕾,刘占涛,贾秀芹,梁瑜.针刺对癫痫模型大鼠杏仁核点燃进程的影响[J].山东中医药大学学报.2007.31(6)：499-500.
[106]杨俊,黄远桂,徐江涛.电针预处理抑制癫痫持续状态诱发的海马区神经元凋亡研究[J].辽宁中医药大学学报.2011.13(3)：104-106.
[107]Racine IU. Modification of seizure activity by electrical stimulation II motorseizure[J]. Electroencephaogrcllin Neurophysiol,1972,32:781-794.
[108]Twlfeian AE,Tseng HC,Baybis M,et al.Differential expression of GABA and glutamate receptor subunits and enzymes involved in GABA metabolism between electrophysiologically identified hippocampal CA1 pyramidal cells and interneurons[J].Epilepsia,2003,44(2):143-14
[109]Nilsen KE,Walker MC.Cock HR,et al.Characterization of the Tetanus Toxin Model of Refractory Focal Neocortical Epilepsy n the Rat[J].Epilepsia(Series4),2005,46(2):179-188
[110]Bertram EH.Temporal lobe epilepsy:where do the seizures really begin[J]?Epilepsy Behav,2009,14(Suppll):32-37.
[111]Sloviter RS.The functional organization of the hippocampal dentate gyrus and its Relevance to the pathogenesis of temporal lobe epilepsy[J].Ann Neurol 1994.35(6):640-654
[112]]Dudek FE,Sutula TP.Epileptogenesis in the dentate gyrus:a critical perspective[J].Prog Brain Res,2007,163:755-773.
[113]Cavazos JE,Cross DJ.The role of synaptic reorganization in mesial temporal lobe epilepsy[J].Epilepsy Behav,2006,8(3):483-493.
[114]Suzuki J.Investigations of Epilepsy with a Mutant Animal(EL Mouse)Model[J].Epilepsia(Series4), SuPPlements,2004,45:2-6
[115]Kudin,P.Debska VG,Vielhaber SE,et al.The Mechanism of Neuroprotection by Topiramate n an Animal Model of Epilepsy [J].Epilepsia(Series4),2004,45(10):1478-1488
[116]王顺,刘军.中医药治疗癫痫综述[J].针灸临床杂志,2007,23(12)：42-44.
[117]程记伟,白宇.癫痫的中医药治疗进展[J].辽宁中医药大学学报,2008,10(4)：64-66.
[118]徐凌川,张华,许昌盛.白首乌化学成分与药理现代研究评述.中医药学刊[J].2003,21(11)：1893-1895,1959.
[119]李洪兵.何首乌的现代药理学研究综述[J].云南中医中药杂志,2012,33(6)：72-75.
[120]凌志扬,房玉良.石斛的化学成分及药理作用[J].中国当代医药,2012,19(5)：13-16.
[121]薛柳华,唐一鹏,洪庆涛,等.天麻素对谷氨酸致培养皮层神经细胞损伤的保护作用[J].北京中医药大学学报,1999,22(1)：39-40.
[122]Lee YS, Ha JH, Yong CS, et al. Inhibitory effects of constituents of Gastrodia elata B1. On glutamate-induced apoptosis in IMR-32 human neuroblastoma cells [J] Arch Pharm Res,1999,22(4):404-409.
[123]李国均.中国药材学[M].北京：中国医药科技出版社,1996：1997.
[124]郭晓恒,严铸云,刘涛,宋登敏,李晓华.僵蚕单体化合物抗惊厥活性[J].中国实验方剂学杂志,2013,19(17)：248-250
[125]于家琨,张景海,王起振,等.东亚钳蝎毒抗癫痫肽作用机制研究[J].沈阳药学院学报,1993,10(1)：55-59
[126]姜春玲,张健,郎明非,等.蝎毒对癫痫敏感性和海马GFAP释放的影响[J].中国应用生理学杂志,1999,15(3)：234-237
[127]姜春玲,张万琴.蝎毒诱导红藻氨酸癫痫大鼠海马内GABA释放的免疫组化观察[J].生理学报,1999,51(6)：609-614
[128]姜春玲,张万琴.蝎毒对癫痫大鼠海马内强啡肽原mRNA表达的影响[J].中国应用生理学杂志,2000,16(1)：72-74
[129]姜春玲,彭岩,张万琴.蝎毒诱导红藻氨酸癫痫大鼠海马内胆囊收缩素原mRNA的表达[J].中国应用生理学杂志,2000,16(2)：108-110
[130]姜春玲,张万琴.蝎毒抗癫痫反复发作的GFAP基因调控机制[J].中国应用生理学杂志,2002,18(4)：406-407
[131]黄迎春,左萍萍.东亚钳蝎提取物对癫痫小鼠大脑皮层NMDA受体和GABAA受体的调节作用[J].时珍国医国药,2007,18(1)：71-73
[132]李浩飞,方明月.五种养心安神中药的抗惊厥作用[J].中国医药导报,2008,5(28)：19-20
[133]山西省药品检验所药理室.远志药材应否去心的研究[J].新医药学志,1975,(4)：46
[134]何巧燕.七味中草药乙醇提取物抗惊厥作用的药效学比较研究.山西医科大学,2007
[135]丁莉,李新玲,邵良.甘松对青霉素致痫大鼠行为学表现及脑电图的影响[J].癫痫与神经电生理学杂志,2010,19(3)：132-135.
[136]李新玲,丁莉,邵良,等.甘松治疗戊四氮致痫大鼠的实验性研究[J].卒中与神经疾病,2010,17(3)：151-178.
[137]龚誉华,程光宇,程为平.补脑止痫散对戊四氮致痫大鼠血清Glu和GABA含量的影响[J].中医药信息,2012,29(4)：105-107.
[138]程为平,董升平,侯伯男,等.中药补脑止痫散对癫痫大鼠海马谷氨酸和γ氨基丁酸含量的影响[J].中国中医急症,2013,22(1)：14-16.
[139]龚誉华,程光宇,程为平.中药补脑止痫散对癫痫大鼠海马神经元凋亡基因Bax和Bcl-2表达的影响[J].环球中医药,2012,5(2)：64-66.
[140]程为平,董升平,何清溪,等.中药补脑止痫散对癫痫大鼠海马c-fos和PKCa表达的影响[J].时珍国医国药,2013,24(6)：1349-1350.
[141]NIH,JiangYW,BoT,etal.C-Fos,N-methyl-d-aspartate receptor 2C,GABA-A-alphal immonoreactivity,seizure latency and neuronal in jury following single or recurrent neonatal seizures in hippocampus of Wistar rat[J].Neurosci Lett,2005,380(12):149-154
[142]Houser CR,Eselapez M.Downregulation of the a5 subunit of the GABAA receptor in the pilocarpine model of temporal lobe epilepsy.Hippocampus,2003,13:633-645
[143]Mathem GW,Pretorius JK,Mendoza D,et al.Hippocampal AMPA and NMDA mRNA Levels correlate with aberrant fascia dentata mossy fiber sprouting in the pilocarpine model of spontaneous limbic epilepsy[J].J Neurosci Res,1998,54(6):734-753.
[144]王群,阮旭中,史庭慧,等.马桑内酯致痫大鼠大脑皮层、海马NMDA受体亚单位1(NMDAR1)mRNA表达的变化[J].中风与神经疾病杂志,2000,17(1)：17-19.
[145]Hopkins S J, Rothwell N J.Cytokines in the nervous system:expression and recognition [J].TINS,1995,18:83-88.
[146]向赟,许晓莉,刘宇炜.戊四氮致痫大鼠脑脊液1L-1β、IL-6含量的变化[J].汉江大学学报,2002,30(4)：20-22.
[147]Donnelly S,Loscher C,Mills,KH,et al.Glycerol induced seizure:involvement of IL-1beta and glutamate[J].Neuroreport,1999,10(9):1821-5.
[148]Bergles DE, Robert JD, Somogyi P,et al.Glutamatergic synapses on oligodendrocyte precursor cells in hippocampus[J].Nature,2000,405(6783):187-191.
[149]Mach QH, PersingerMA.Behavioral changes with brief exposures to weak magnetic fields patterned to stimulate long-term potentiation[J]. Brain Res,2009,1261:45-53.
[150]Zhao Q,Marolewski A,Rusche JR,et al.Effects of uridine in models of epileptogenesis and seizures[J].Epilepsy Res,2006,70(1):73-82.
[151]Calabrese V,Guagliano E,Sapienza M,et al.Redox regulation of cellular stress response in aging and neuro degenerative disorders:role of vitagenes[J]. Neurochem Res,2007,32(45):753-773.
[152]Rodrigo MV,Giacomo S,Lobna A I,et al.Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders[J]. Curr Pharm Des,2009,15(14):1595-1611.
[153]郑乃智,王敏,刘玉霞,卢幸明.癫痫预防研究进展[J].国际神经病学神经外科学杂志,2009,36(4)：348-351.
[154]Pavuluri MN, Henry DB, Moss M,et al.Effectiveness of lamotrigine in maintaining symptom control in pediatric bipolar disorder[J]. J Child and Adolesc Psychopharmacol,2009,19(1):75-82.
[2]Sadi-Pooya A.A, Hojabri K.Risk factors for childhood epilepsy:a case-control study. Epilepsy & Behavior,2005,6(2):203-206.
[3]Daoud A.S, Batieha A, Bashtawi M,et al.Risk factors for childhood epilepsy:a case-control study from Irbid,Jordan[J].Seizure,2003,12(3):170-174.
[4]曾军,洪震,黄茂盛等.人群癫痫危险因素及社会心理因素病例对照研究.中华流行病杂志,2003,24(2)：116-118.
[5]Liang J, Zhang Y, Chen Y, et al.Common polymorphisms in the CACNAIH gene associated with childhood absence epilepsy in Chinese Han population.[J]Ann Hum Genet.2007,71(Pt 3):325-35
[6]Cruneli V, Leresche N. Childhood absence epilepsy:genes, channels, neurons and networks[J].Nat Rev Neurosci.2002;3:371-82
[7]Gourfinkel-An I, Baulac S, Nabbout R, Ruberg M, Baulac M, Brice A et al.Monogenic idiopathic epilepsies[J]. Lancet Neurol.2004;3:209-18
[8]Delgado-Escueta AV, Medina MT, Serratosa JM, Castroviejo IP, Gee MN, Weissbecker K et al.Mapping and positional cloning of common idiopathic generalized epilepsies:juveile myoclonus epilepsy and childhood absence epilepsy[J].Adv Neurol 1999;79:351-74
[9]Jones-Davis DM,Macdonald RL.GABA(A) receptor function and pharmacology in epilepsy and status epilepticus[J]. Curr Opin Pharmacol.2003;3:12-8
[10]Lerche H,Jurkat-Rott K, Lehmann-Horn F. Ion channel and epilepsy[J]. Am J Med Genet,2001,106(2):146-159.
[11]Wallace RH,Wang DW,Singh R,et al.Febrile seizures and generalized epilepsy associated with a mutation in the Na+channelβ1 subunit gene SCNlB[J].Nat Gent, 1998,19(4):366-370.
[12]Steinlein OK,Noebels JL.Ion channel and epilepsy in man and mouse[J].Curr Opin Genet Dev,2000,10(3):286-291.
[13]Cossette P,、liu L,Brisebois K,et al. Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy.Nat Genet[J],2002,31 (2):184-189
[14]Haug K, Warnstedt M, Alekov AK,et al.Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies[J].Nat Genet,2003,33(4):527-532[15]胡元元,何善述,徐仁泗,等.神经元GABA合成、分解和分泌与癫痫发病的研究[J].中风与神经疾病杂志,2002,18(3)：134-136.
[16]郭文GABAA受体的研究进展[J].国外医学生理、病理科学与临床分册,1999,19(3)：161-164.
[17]Freund TF, Katona I. Perisomatic inhibition[J]. Neuron,2007,56:33-42.
[18]张力,张丹参,张士善.外周GABA受体研究进展[J].中国药理学通报,1990.
[19]王尧,杜子威.神经生物化学与分子生物学[M].北京：人民卫生出版社,1997.
[20]Houser CR,Eselapez M.Vulnerability and plastieity of the GABA system in the pilocarpine model of spontaneous recurrent seizures[J]. Epilepsy Res,1996,26(I):207-218
[21]Bormann J.Trends Pharmacol Sci[J].2000,21:16-19
[22]小川纪雄,冯剑波译.脑受体[M].北京：北京医科大学中国协和医科大学联合出版社,1997.
[23]Misgeld U,Bijak M,Jarolimek W.A physiological role for GABAB receptors and the effects of baclofen in the mammalian central nervous system[J].Prog Neurobiol,1995,46(4):423-462
[24]Simon J,Wakimoto H,Fujita N,et al.Analysis of the set of GABAA receptor genes in the human genome[J]. Biol Chem,2004,279(40):41422-41435
[25]Corringer PJ, Le Novere N,Changeux JP.Nicotinic receptors at the amino acid level[J].Annu Rev Pharmacol Toxicol,2000,40:431-458
[26]McKernan RM,Whiting pJ.Which GABAA-receptor subtypes really occur in the brain?Trends Neurosci,1996,19(4):139-14
[27]Lynch M, Sutula T. Recurrent excitatory connectivity in the dentate gyrus of kindled and kainic acid-treated rats[J].J Neurophysiol,2000,83(2):693-704.
[28]Fukao K,Momiyama T,Ishihara K,et al.Inhibition by γ-aminobutyric acid system activation of epileptic seizures in spontaneously epileptic rats[J].Jpn J Pharmacol,1998,76(4):387-396
[29]Rossler AS,Launay JM,Venaut P,et al.Change in benzodiazepine binding in a subkindling situation[J]. Epilepsia,2000,41(Suppl 6):586.
[30]Gibbs JWIII,Shumate MD,Coulter DA.Differential epilepsy associated alterations in postsynaptic GABAA receptor function in dentate granule and CA1 neurons[J].J Neurophysiol,1997,77(4):1924-193
[31]Gibbs JWIII,Berkow SG,Morton L,et al.Physiological analysis of Rasmussen's encephalitis:Patch clamp recordings of altered inhibitory neurotransmitter function in ressected frontal cortical tissue.Epilepsia,1996,37(suppl 5):79
[32]薄涛,陈勇,毛定安,等.新生大鼠反复惊厥对脑内Y-氨基丁酸A受体α1和γ2亚单位表达的长期影响[J].北京大学学报(医学版),2006,38(6)：628-633.
[33]陆钦池,苗玲,蔡琰.癫痫持续大鼠模型的GABAA受体亚单位αl的mRNA表达及受体配体结合的变化[J].脑与神经疾病杂志,2001,9(3)：133-136
[34]Loup F,Wieser HG,Yonekawa Y,et al.Selective alterations in GABAA receptor subtypes in human temporal lobe epilepsy[J].J Neurosci,2000,20(14):5401-5419.
[35]]Meguro R,Lu ZW,Gavrilovici C,et al.Static.transient and permanent organisation of GABAA[J].Neurochemistry,2004,91(1):144
[36]刘智良,徐如祥,姚志彬,等GABAB受体对大鼠海马CA1区锥体细胞突触传递的作用[J].中华神经医学杂志,2006.
[37]Grifa A,Totaro A,Rommen S JM,et al.GABA(gamma-aminobutyric acid)neurotransmission:identification and fine mapping of human GABAB receptor gene[J].Biochem Biophys Res Commun,1998,50(2):240-245.
[38]KauPmann K,huggel K,Heid J,et al.Expression cloning of GABAB-receptors uncovers similarity to metabotropic glutamate receptors[J].Nature,1997,386(6622):239-246.
[39]Furtinger S,Bettle B,Sperk G.Altered expression of GABAB receptor in the hippocampus after kainic acid-induced seizure n rats[J].Mol Brain Res,2003,113(1):107-115.
[40]陆钦池,蔡琐.AY-9944大鼠失神样痫性发作模型的GABAB受体R1亚单位基因表 达改变[J].脑与神经疾病杂志,2002,10(5)：279-281
[41]Sehuler V,Lusehe C,Blanehet C,et al.Epilepsy,hyperalgesia,impaired memory,and loss of pre-and postsynaptic GABA(B) responses in mice lacking GABA(B(1))[J]. Neuron,2001,31(1):47-58
[42]Gambardella A,Manna I,Labate A,et al.GABA(B) receptorl polymorphism(G1465A) s associated with temporal obe epilepsy)[J].Neurology,2003,60(4):560-563
[43]Avoli M,Benini R,Guzman P,et al.GABA(B) receptor activation and limbic network ictogenesis)[J].Neuropharmacology,2004,46(1):43-51
[44]Bowery NG, Enna S J.y-Amino butyric acid B receptors:first of the functional metabotropic heterodimers. Pharmacol[J].Exp,2000,292:1-7.
[45]Chebib M,Johnston GA.The"ABC"ofGABA receptors:a brief review[J].Clin Exp Pharmacol Physiol,1999,26(11):937-940
[46]Graham AR,Johnston,Phan KL,et al.GABAc receptors as drug targets[J].Curr Drug Targ CNS Neurol Disord,2003,2(4):260-269
[47]Lloyd KG,Bossi L,Morselli PL,et al.Alterations of GABA-mediated synaptic transmission in human epilepsy[J].Adv Neurol.1986;44:1033-44.
[48]Savic I.Persson A,Roland P,et al.In-vivo demonstration of reduced Benzodiazepine receptor binding n human epileptic foe i[J].Lancet.1988; 15;2(8616):863-6
[49]王晓梅,关毅敏,张文利,等.癫痫患者脑脊液中GABA、Glu、As的变化及其临床意义[J].中风与神经疾病杂志,1996,13(6)：348-350.
[50]田发发.点燃癫痫模型中脑组织兴奋性氨基酸的变化[J].湖南医科大学学报,2002,27(4)：319-31].
[51]Dingledine R,Borges K,Bowie D,et al.The glutamate receptor ion channels[J]. Pharmacological Reviews,1999,51(1):7-61
[52]Paoletti P,Neyton J.NMDA receptor subunits:function and pharmacology[J].Current Opinion in Pharmacology,2007,7(1):39-47
[53]Chrysanthy J,Friederike B,Miehael M,et al.Bloekade of NMDA receptors and apoptic neurodegeneration in the developing brain[J].Seienee,1999,283:7
[54]Yu SP,Yeh CH,Strasser U,et al.NMDA receptor mediated K+effiux and neuronal apoptosis[J].Science,1999,284:336
[55]Angeka CE, Robert KS, Shih-Chieh C, et al. Role of synaptic metabotropic glutamate receptors in epileptic form discharges in hippocampal slices[J].J Neurophysiol,2002,88(4):1625-1633.
[56]Bo T, Jiang Y, Cao H, et al. Long-term effects of seizures in neonatal rats on spatial learning ability and N-methyl-D-aspartate receptor expression in the brain[J].Brain Res Dev Brain Res,2004,152(2):137-142.
[57]Wang F, Smith NA,Xu Q,Fujita T,Baba A,Matsuda T,Takano T, Bekar L, Nedergaard M.Astrocytes modulate neural network activity by Ca2+-dependent uptake of extracellular K+[J].Sci Signal 2012;5(218):26
[58]Nedergaard M, Verkhratsky A.Artifact versus reality-How astrocytes contribute to synaptic events[J].Glia.2012. doi:10.1002/glia.22288.
[59]Appaix F.Girod S,Boisseau S,Romer J,Vial JC,Albrieux M,Maurin M,Depaulis A, Guillemain I, van der Sanden B.Specific in vivo staining of astrocytes in the whole brain after intravenous injection of sulforhodamine dyes[J].PLoS One 2012;7(4):e35169
[60]Oberheim NA,Tian GF,Han XN,et al.Loss of Astrocytic Domain Organization in the Epileptic Brain[J].J Neurosci 2008;28(13) 3264-3276
[61]Simatov R,Crispino M,Hoe W,et al.Changes in expression of neuronal and glial glutamate transportersin rat hippocampus following kainite induced seisure activity[J].Brain Res,1999,65 (1):112-116.
[62]Turrin NP,Rivest S.Innate immune reaction in response to seizures:implications for the neuropathology associated with epilepsy[J]. Neurobiology,2004,16(2) 321-334.
[63]杜静,方敏,龚非力,等.癫痫患者脑组织TNF-αmRNA、IL-6 mRNA以及HLA-Ⅱ抗原表达的改变[J].同济医科大学学报,2000,29(2)：111-113.
[64]Minami M, Kuraishi Y,Yamaguchi T,et al.Convulsants induce interleukin-1 beta messenger RNA in rat brain [J]. Biochem Biophys Res Commun,1990,171 (2):832-837.
[65]Vezzani A,Conti M,De Luigi A,et al.Interleukin-lbeta immunoreactivity and micro glia are enhanced in the rat hippocampus by focal kainate application:functional evidence for enhancement of electrographic seizures[J].J Neurosci,1999,19(12):256-5065.
[66]李平,李正莉,朱长庚,等.白细胞介素-1p对Fos蛋白表达的影响及其在癫痫发作中的作用[J].中国组织化学与细胞化学杂志,2003,12(3)：245-249
[67]牛廷献,罗晓红,史智勇,高福兴.癫痫大鼠血清和脑组织IL-1β、IL-6和TNF-α水平变化[J].放射免疫学杂志,2005,18(4)：256-259
[68]Hirano T, Yasukawa k, Harada H,et al. Complementary DNA for a novel human interleukin (BSF-2) that nduced B-lymphocytes to produce immunoblobulins[J].Nature,1986,324:73-76.
[69]Muraguchi AT,Hirano B,Tang T,et al.The essential role of B cell stimulatory factor 2(BSF-2/IL-6) for the terminal differentiation of B-cells[J].J Exp Med,1988, 167:332-344.
[70]Guerne PA,Carson DA,Lotz M. IL-6 production bu human articular chondrocytes [J]. J Immunol,1990,144:499-505.
[71]Campell IL,Abraham CR,Masliah E,et al.Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin-6[J].Pro Natl Acad Sci USA.1993,90(21):10061.
[72]Petloal J.Palmio J,Korhonen L,el al.Interleukin-6 and interleukin-1 erceptor antagonist in cerebrospinal fluid from patients with recent tonic-clonic seizures[J].Epilepsy Res,2000,41(3):205-211.
[73]杜静,方敏,龚非力,等.癫痫患者脑组织TNF-αmRNA、IL-6 mRNA以及HLA-Ⅱ抗原表达的改变[J].同济医科大学学报,2000,29(2)：111-113.
[74]ZHU Xiaoxin,LI Zhengli,ZHU Changgen,et al.Changes in Behavior and Amino Acid Neurotransmitters in the Brain of Rats with Seizure Induced by IL-1 or IL-6[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2005,25(3):236-239.
[75]Crespel A,Coubes P,,Rousset MC,Brana C, Rougier A, Rondouin G, Bockaert J, Baldy-Moulinier M, Lerner-Natoli M.2002. Inflammatory reactions in human medial temporal lobe epilepsy with hippocampal sclerosis[J]. Brain Res 952:159-169.
[76]Kharatishvili I, Nissinen JP, McIntosh TK, Pitkanen A.2006. A model of posttraumatic epilepsy induced by lateral fluid-percussion brain injuryin rats[J]. Neuroscience 140:685-697.
[77]Pitkanen A, Immonen RJ, Grohn OH, Kharatishvili I.2009. From traumatic brain injury to posttraumatic epilepsy:what animal models tell us about the process and treatment options[J]. Epilepsia 50(Suppl 2):21-29.
[78]Hayashi K, Ueshima S, Ouchida M, Mashimo T, Nishiki T, Sendo T, Serikawa T, Matsui H, Ohmori I.2011. Therapy for hyperthermia-induced seizures in Scnla mutant rats[J]. Epilepsia 52:1010-1017.
[79]Zheng XY, Zhang HL, Luo Q, Zhu J.2011. Kainic acid-induced neuro-degenerative model:potentials and limitations[J]. J Biomed Biotechnol 2011:457079.
[80]Bae EK, Jung KH, Chu K, Lee ST, Kim JH, Park KI, Kim M, Chung CK, Lee SK, Roh JK.2010. Neuropathologic and clinical features of human medial temporal lobe epilepsy[J]. J Clin Neuro16:73-80.
[81]Yang T, Zhou D, Stefan H.2010. Why mesial temporal lobe epilepsy with hippocampal sclerosis is progressive:uncontrolled inflammation drives disease progression[J]. J Neurol Sci 296:1-6.
[82]C P Panayiotopoulos,吴立文,任连坤,等.癫痫-发作和综合征的诊断与治疗[M].北京：中国协和医科大学出版社,2008：455-485
[83]Webster WS, Howe AM, Abela D,et al.The relationship between cleft lip,maxillary hypoplasia,hypoxia and phenytoin[J].Curr Pharm Des,2006,12(12):1431-1448.
[84]Yasser Y.Obstetric and gynecologic care of women with epilepsy[J]. Epilepsia,1998,39(Suppl18):S17
[85]Samren EB,Cornelia MVD,Chritiaens GCML.et al.Antiepileptic drug regimens and major congenital abnormalities in the offspring[J].Ann Neurol,1997,46(5):739
[86]Cerminara C,Montanaro ML,Curatolo P,et al.Lamotrigine induced seizure aggravation and negative myoclonus n diopathic rolandic epilepsy[J].Neurology,2004,63(2):373-375.
[87]Sazgar M,Bourgeo is BF.Aggravation of epilepsy by antiepileptic drugs[J]. Pediatr Neurol,2005,33(4):227-234.
[88]冯波,王建军,魏装鹏,等.外伤性癫痫136例临床分析[J].临床外科杂志,2008,16(6)419-420.
[89]晋金兰,庄汉屏,陈英.脑外伤后癫痫的临床研究进展[J].中国临床神经学,2007,15(1)：87-91.
[90]公方和,漆松涛,刘承勇,邱炳辉.抗癫痫药对神经外科手术后癫痫的预防作用[J].广东医学,2006,27(2)：268-269.
[91]LFM Beenen,J Lindeboom,DGA Kasteleijn-Nolst Trenite,et al.Comparative Domparative double blind clinical trial of phenytoin and sodium valproate as anticonvulsant prophylaxis after craniotomy:efficacy,tolerability,and cognitive effects[J].Neurol Neurosurg Psychiatry,1999.67:474-480.
[92]Angeleri F,Majkowski J,Cacchio G,et al.Post traumatic epilepsy risk factors:one year pospective study after head injury[J].Epilepsia40.1222-1230.
[93]Temkin NR,Dikmen SS,Anderson GD,et al.Valproate therapy for prevention of posttraumatic seizures:a randomized trial[J].J Neurisurg1999.91:593-600.
[94]许文洲.从经方治痫验案谈其临床分型[J].中国民间疗法,2001,9(6)：8-9.
[95]王建国,邵景云.石葛蒲治癫痫大发作有良效[J].四川中医,1996,14(11)：23
[96]杨安婷,林秀萍.中药赭石治疗小儿癫痫121例临床体会[J].黑龙江中医药,1998,(5)：269
[97]高广英,范珍花.蜥蜴治疗小儿癫痫2例[J].中国民族民间医药杂志,2001,(51)：245
[98]王晓鹏,耿连霞,焦玉平,等.刺五加的抗癫痫作用及分析[J].河北中医,1998,20(5)：269-270,
[99]解旭东,冀风云,王婷,等.银杏叶提取物辅助治疗癫痫临床观察[J].脑与神经疾病杂志,2000,8(3)：172-173.
[100]邓元江,王净净.穴位埋线加小剂量抗痫西药治疗癫痫全身强直阵挛发作临床观察[J].中国针灸,2001,21(5)：271
[101]尚希贤.中医防治癫痫初探[J].陕西中医,1996,17(5)：212-213.
[102]榻达科,张汉伟,张刚利,赵利军.穴位埋线对癫痫大鼠急性发作潜伏期及体重的影响[J].实验中医药学.2012,13(2)：26-29.
[103]杜淑娟,杨丽新.袁美凤教授治疗癫痫经验[J].山西中医学院学报,2006,7(3)： 45-46.
[104]符冰,李红,张家维.辨证取穴药线埋植治疗癫痫的临床研究[J].甘肃中医,2004,17(9)：1
[105]杨丽卿,岳旺,王蕾,刘占涛,贾秀芹,梁瑜.针刺对癫痫模型大鼠杏仁核点燃进程的影响[J].山东中医药大学学报.2007.31(6)：499-500.
[106]杨俊,黄远桂,徐江涛.电针预处理抑制癫痫持续状态诱发的海马区神经元凋亡研究[J].辽宁中医药大学学报.2011.13(3)：104-106.
[107]Racine IU. Modification of seizure activity by electrical stimulation II motorseizure[J]. Electroencephaogrcllin Neurophysiol,1972,32:781-794.
[108]Twlfeian AE,Tseng HC,Baybis M,et al.Differential expression of GABA and glutamate receptor subunits and enzymes involved in GABA metabolism between electrophysiologically identified hippocampal CA1 pyramidal cells and interneurons[J].Epilepsia,2003,44(2):143-14
[109]Nilsen KE,Walker MC.Cock HR,et al.Characterization of the Tetanus Toxin Model of Refractory Focal Neocortical Epilepsy n the Rat[J].Epilepsia(Series4),2005,46(2):179-188
[110]Bertram EH.Temporal lobe epilepsy:where do the seizures really begin[J]?Epilepsy Behav,2009,14(Suppll):32-37.
[111]Sloviter RS.The functional organization of the hippocampal dentate gyrus and its Relevance to the pathogenesis of temporal lobe epilepsy[J].Ann Neurol 1994.35(6):640-654
[112]]Dudek FE,Sutula TP.Epileptogenesis in the dentate gyrus:a critical perspective[J].Prog Brain Res,2007,163:755-773.
[113]Cavazos JE,Cross DJ.The role of synaptic reorganization in mesial temporal lobe epilepsy[J].Epilepsy Behav,2006,8(3):483-493.
[114]Suzuki J.Investigations of Epilepsy with a Mutant Animal(EL Mouse)Model[J].Epilepsia(Series4), SuPPlements,2004,45:2-6
[115]Kudin,P.Debska VG,Vielhaber SE,et al.The Mechanism of Neuroprotection by Topiramate n an Animal Model of Epilepsy [J].Epilepsia(Series4),2004,45(10):1478-1488
[116]王顺,刘军.中医药治疗癫痫综述[J].针灸临床杂志,2007,23(12)：42-44.
[117]程记伟,白宇.癫痫的中医药治疗进展[J].辽宁中医药大学学报,2008,10(4)：64-66.
[118]徐凌川,张华,许昌盛.白首乌化学成分与药理现代研究评述.中医药学刊[J].2003,21(11)：1893-1895,1959.
[119]李洪兵.何首乌的现代药理学研究综述[J].云南中医中药杂志,2012,33(6)：72-75.
[120]凌志扬,房玉良.石斛的化学成分及药理作用[J].中国当代医药,2012,19(5)：13-16.
[121]薛柳华,唐一鹏,洪庆涛,等.天麻素对谷氨酸致培养皮层神经细胞损伤的保护作用[J].北京中医药大学学报,1999,22(1)：39-40.
[122]Lee YS, Ha JH, Yong CS, et al. Inhibitory effects of constituents of Gastrodia elata B1. On glutamate-induced apoptosis in IMR-32 human neuroblastoma cells [J] Arch Pharm Res,1999,22(4):404-409.
[123]李国均.中国药材学[M].北京：中国医药科技出版社,1996：1997.
[124]郭晓恒,严铸云,刘涛,宋登敏,李晓华.僵蚕单体化合物抗惊厥活性[J].中国实验方剂学杂志,2013,19(17)：248-250
[125]于家琨,张景海,王起振,等.东亚钳蝎毒抗癫痫肽作用机制研究[J].沈阳药学院学报,1993,10(1)：55-59
[126]姜春玲,张健,郎明非,等.蝎毒对癫痫敏感性和海马GFAP释放的影响[J].中国应用生理学杂志,1999,15(3)：234-237
[127]姜春玲,张万琴.蝎毒诱导红藻氨酸癫痫大鼠海马内GABA释放的免疫组化观察[J].生理学报,1999,51(6)：609-614
[128]姜春玲,张万琴.蝎毒对癫痫大鼠海马内强啡肽原mRNA表达的影响[J].中国应用生理学杂志,2000,16(1)：72-74
[129]姜春玲,彭岩,张万琴.蝎毒诱导红藻氨酸癫痫大鼠海马内胆囊收缩素原mRNA的表达[J].中国应用生理学杂志,2000,16(2)：108-110
[130]姜春玲,张万琴.蝎毒抗癫痫反复发作的GFAP基因调控机制[J].中国应用生理学杂志,2002,18(4)：406-407
[131]黄迎春,左萍萍.东亚钳蝎提取物对癫痫小鼠大脑皮层NMDA受体和GABAA受体的调节作用[J].时珍国医国药,2007,18(1)：71-73
[132]李浩飞,方明月.五种养心安神中药的抗惊厥作用[J].中国医药导报,2008,5(28)：19-20
[133]山西省药品检验所药理室.远志药材应否去心的研究[J].新医药学志,1975,(4)：46
[134]何巧燕.七味中草药乙醇提取物抗惊厥作用的药效学比较研究.山西医科大学,2007
[135]丁莉,李新玲,邵良.甘松对青霉素致痫大鼠行为学表现及脑电图的影响[J].癫痫与神经电生理学杂志,2010,19(3)：132-135.
[136]李新玲,丁莉,邵良,等.甘松治疗戊四氮致痫大鼠的实验性研究[J].卒中与神经疾病,2010,17(3)：151-178.
[137]龚誉华,程光宇,程为平.补脑止痫散对戊四氮致痫大鼠血清Glu和GABA含量的影响[J].中医药信息,2012,29(4)：105-107.
[138]程为平,董升平,侯伯男,等.中药补脑止痫散对癫痫大鼠海马谷氨酸和γ氨基丁酸含量的影响[J].中国中医急症,2013,22(1)：14-16.
[139]龚誉华,程光宇,程为平.中药补脑止痫散对癫痫大鼠海马神经元凋亡基因Bax和Bcl-2表达的影响[J].环球中医药,2012,5(2)：64-66.
[140]程为平,董升平,何清溪,等.中药补脑止痫散对癫痫大鼠海马c-fos和PKCa表达的影响[J].时珍国医国药,2013,24(6)：1349-1350.
[141]NIH,JiangYW,BoT,etal.C-Fos,N-methyl-d-aspartate receptor 2C,GABA-A-alphal immonoreactivity,seizure latency and neuronal in jury following single or recurrent neonatal seizures in hippocampus of Wistar rat[J].Neurosci Lett,2005,380(12):149-154
[142]Houser CR,Eselapez M.Downregulation of the a5 subunit of the GABAA receptor in the pilocarpine model of temporal lobe epilepsy.Hippocampus,2003,13:633-645
[143]Mathem GW,Pretorius JK,Mendoza D,et al.Hippocampal AMPA and NMDA mRNA Levels correlate with aberrant fascia dentata mossy fiber sprouting in the pilocarpine model of spontaneous limbic epilepsy[J].J Neurosci Res,1998,54(6):734-753.
[144]王群,阮旭中,史庭慧,等.马桑内酯致痫大鼠大脑皮层、海马NMDA受体亚单位1(NMDAR1)mRNA表达的变化[J].中风与神经疾病杂志,2000,17(1)：17-19.
[145]Hopkins S J, Rothwell N J.Cytokines in the nervous system:expression and recognition [J].TINS,1995,18:83-88.
[146]向赟,许晓莉,刘宇炜.戊四氮致痫大鼠脑脊液1L-1β、IL-6含量的变化[J].汉江大学学报,2002,30(4)：20-22.
[147]Donnelly S,Loscher C,Mills,KH,et al.Glycerol induced seizure:involvement of IL-1beta and glutamate[J].Neuroreport,1999,10(9):1821-5.
[148]Bergles DE, Robert JD, Somogyi P,et al.Glutamatergic synapses on oligodendrocyte precursor cells in hippocampus[J].Nature,2000,405(6783):187-191.
[149]Mach QH, PersingerMA.Behavioral changes with brief exposures to weak magnetic fields patterned to stimulate long-term potentiation[J]. Brain Res,2009,1261:45-53.
[150]Zhao Q,Marolewski A,Rusche JR,et al.Effects of uridine in models of epileptogenesis and seizures[J].Epilepsy Res,2006,70(1):73-82.
[151]Calabrese V,Guagliano E,Sapienza M,et al.Redox regulation of cellular stress response in aging and neuro degenerative disorders:role of vitagenes[J]. Neurochem Res,2007,32(45):753-773.
[152]Rodrigo MV,Giacomo S,Lobna A I,et al.Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders[J]. Curr Pharm Des,2009,15(14):1595-1611.
[153]郑乃智,王敏,刘玉霞,卢幸明.癫痫预防研究进展[J].国际神经病学神经外科学杂志,2009,36(4)：348-351.
[154]Pavuluri MN, Henry DB, Moss M,et al.Effectiveness of lamotrigine in maintaining symptom control in pediatric bipolar disorder[J]. J Child and Adolesc Psychopharmacol,2009,19(1):75-82.
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |